The need for repeat colonoscopy could be predicted

Risk stratification has the potential to dramatically change colorectal cancer screening strategies.

A team of researchers from Luxembourg has found a simple panel of eight genetic biomarkers may be able to identify which patients are at a high risk for developing CRC following a screening colonoscopy, according to a Medscape report.

The researchers presented their data at the 17th World Congress on Gastrointestinal Cancer held July 1 to July 4 in Barcelona, Spain.

The test uses standard blood samples and could be done at any time. The researchers found that a panel with just three of the eight studied biomarkers was almost as accurate. The test could serve as a low-cost option for determining which patients are candidates for repeat colonoscopy, according to the report.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

ASC_GI_300x250

Featured Webinars

Featured Whitepapers

Featured Podcast